Drug-Drug Interaction Study in Healthy Japanese Adult Subjects
Phase 1
Completed
- Conditions
- Central Retinal Artery Occlusion
- Registration Number
- JPRN-jRCT2031210444
- Lead Sponsor
- Ohtori Akira
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Healthy Japanese male and female
- 20-55 years of age at the time of the informed consent
- Other protocol-specified inclusion criteria may apply
Exclusion Criteria
- History or complications of diseases such as the heart, kidneys, liver, and brain that are considered inappropriate for participation in this clinical trial
- History or complications of serious drug allergies or food allergies
- Judged by the investigator, etc. to be ineligible for this clinical trial
- Other protocol-specified exclusion criteria may apply
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plasma concentration of compound(s)
- Secondary Outcome Measures
Name Time Method